Invasive aspergillosis: Is treatment with "inexpensive" amphotericin B cost saving if "expensive" voriconazole is only used on demand?

Invasive aspergillosis: Is treatment with "inexpensive" amphotericin B cost saving if "expensive" voriconazole is only used on demand?

Bibliographic Details
Main Authors:	G Schnetzler, C Roberts
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2006-10-01
Series:	Swiss Medical Weekly
Subjects:	Voriconazole renal failure Nephrotoxicity Hospitalisation resources Costeffectiveness analysis aspergillosis
Online Access:	https://www.smw.ch/index.php/smw/article/view/654

Similar Items

Orbital Aspergillosis: Voriconazole – The New Standard Treatment
by: Derek H. Ohlstein, et al.
Published: (2012-02-01)

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain
by: Grau S, et al.
Published: (2016-12-01)

Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis
by: Sacha Sarfati, et al.
Published: (2022-07-01)

Successful treatment of multiple intracerebral aspergillosis with voriconazole alone in an Egyptian diabetic patient with autoimmune hemolytic anemia
by: Hamdy Ibrahim, et al.
Published: (2023-10-01)

Rechallenge of voriconazole successfully tolerated after hepatic toxicity
by: O. Narumoto, et al.
Published: (2020-01-01)

Invasive aspergillosis: results of multicenter study
by: N. N. Klimko, et al.
Published: (2014-09-01)

Invasive aspergillosis: results of multicenter study
by: N. N. Klimko, et al.
Published: (2014-09-01)

Nebulised surface-active hybrid nanoparticles of voriconazole for pulmonary Aspergillosis demonstrate clathrin-mediated cellular uptake, improved antifungal efficacy and lung retention
by: Ranjot Kaur, et al.
Published: (2021-01-01)

Voriconazole-Induced Hepatotoxicity in a Patient with Pulmonary Aspergillosis: A Case Report
by: Gu L, et al.
Published: (2023-08-01)

Hyperlipidemia Caused by Voriconazole: A Case Report
by: Wu J, et al.
Published: (2021-02-01)

Invasive aspergillosis of tympanomastoid cavity
by: Santosh Kumar Swain, et al.
Published: (2019-01-01)

Efficacy and safety of voriconazole in the treatment of invasive pulmonary aspergillosis in patients with liver failure: study protocol for a randomized controlled clinical trial
by: Xue Yu, et al.
Published: (2023-12-01)

Incidence of acute kidney injury in dogs with systemic mycotic infections treated with amphotericin B (1996‐2020)
by: Jennifer C. Chan, et al.
Published: (2023-05-01)

Renal aspergillosis after COVID‐19‐associated pulmonary aspergillosis: A case report
by: Roya Ghasemian, et al.
Published: (2023-09-01)

A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model
by: Taotao Wang, et al.
Published: (2018-06-01)

Intracranial abscess due to disseminated aspergillosis in a renal transplant recipient - A case report
by: Sashi Kiran Annavarajula, et al.
Published: (2021-01-01)

Chronic pulmonary aspergillosis - case series and review of Indian literature
by: Vikas Marwah, et al.
Published: (2021-01-01)

Treatment of Aspergillosis
by: Jeffrey D. Jenks, et al.
Published: (2018-08-01)

Treatment of Primary Pulmonary Aspergillosis: An Assessment of the Evidence
by: Ethan R. Stewart, et al.
Published: (2016-09-01)

Pharmacoeconomic evaluation of isavuconazole, posaconazole, and voriconazole for the treatment of invasive mold diseases in hematological patients: initial therapy prior to pathogen differential diagnosis in China
by: Guangxin Han, et al.
Published: (2023-12-01)

Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave
by: Robbert G. Bentvelsen, et al.
Published: (2022-01-01)

Clinical and economic analysis of voriconazole using for treatment of invasive aspergillosis in Russian Federation
by: V. I. Ignatieva, et al.
Published: (2015-06-01)

Clinical and economic analysis of voriconazole using for treatment of invasive aspergillosis in Russian Federation
by: V. I. Ignatieva, et al.
Published: (2015-06-01)

Management of pulmonary aspergillosis in children: a systematic review
by: Vito Terlizzi, et al.
Published: (2023-03-01)

Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes
by: Baddley John W, et al.
Published: (2013-01-01)

Fatal invasive aspergillosis caused by Aspergillus niger after bilateral lung transplantation
by: Enora Atchade, et al.
Published: (2017-09-01)

Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis
by: Milo Gatti, et al.
Published: (2023-04-01)

Clinical Risk Score for Invasive Pulmonary Aspergillosis in Patients With Liver Failure: A Retrospective Study in Zhejiang
by: Xuan Zhang, et al.
Published: (2021-11-01)

Spinal aspergillosis: a rare clinical case and a review of the literature
by: Denis G. Naumov, et al.
Published: (2023-06-01)

Treatment of invasive fungal infections: stability of voriconazole infusion solutions in PVC bags
by: Andréa I.H. Adams, et al.

A case of treatment with voriconazole for chronic progressive pulmonary aspergillosis in a patient receiving tacrolimus for dermatomyositis-associated interstitial lung disease
by: Eisuke Mochizuki, et al.
Published: (2015-01-01)

Amphotericin B May Decrease the Serum Level of Voriconazole: A Case Report and Brief Review of Literature
by: Hu Z, et al.
Published: (2022-09-01)

A suspected case of autoinduction of voriconazole metabolism in a patient with cerebral aspergillosis
by: Ferguson MJ, et al.
Published: (2017-09-01)

Successful treatment of cerebral aspergillosis: case report of a patient with T-cell large granular lymphocytic leukemia (T-LGL)
by: Amin T. Turki, et al.
Published: (2017-12-01)

Echocardiographic quantification of atherosclerosis leads to cost-effective treatment with statins
by: V Barbosa
Published: (2005-01-01)

Evaluación de políticas para el aumento de cobertura escolar en el nivel bachillerato en Ecuador
by: Flores-Poveda, José, et al.
Published: (2016-12-01)

In vitro susceptibilities of fungal isolates against amphotericin B and voriconazole in Aspergillus keratitis: A comparative study
by: Niranjan Nayak, et al.
Published: (2013-01-01)

Comparison of the activities of amphotericin B, itraconazole, and voriconazole against clinical and environmental isolates of Aspergillus species
by: Richa Misra, et al.
Published: (2011-01-01)

Survival in a pediatric patient with cerebral aspergillosis: A case report
by: Ana Paula Ramírez-Acosta, et al.
Published: (2024-01-01)

Successful Treatment of Disseminated Fusariosis with the Combination of Voriconazole and Liposomal Amphotericin B
by: Nur Efe İris, et al.
Published: (2016-11-01)